Professional Documents
Culture Documents
2002 - AWESOME Study Trial - Cabg or ICP After CABG in Symtomatic Patients
2002 - AWESOME Study Trial - Cabg or ICP After CABG in Symtomatic Patients
2002 - AWESOME Study Trial - Cabg or ICP After CABG in Symtomatic Patients
11, 2002
© 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00
Published by Elsevier Science Inc. PII S0735-1097(02)02560-3
In the U.S., an estimated 300,000 coronary artery bypass increasing number and proportion of the patients with acute
graft (CABG) surgeries are done yearly at an estimated cost coronary syndromes and stable angina who are being eval-
of $10 billion (1). Because grafts may clot or develop uated for revascularization (1). The Society for Thoracic
atherosclerotic lesions, and because coronary artery disease Surgery database of 594,059 CABG operations included
progresses in other segments of the coronary tree, eventually 8.6% to 10.4% reoperations per year from 1987 to 1997
patients with prior CABG return with recurrent symptoms (3– 6).
(2). The operative mortality of reoperations is distinctly Percutaneous coronary intervention (PCI) has been used
higher than the mortality of first-time operations (1). to treat medically refractory myocardial ischemia in patients
Reoperative morbidity is also higher than for initial surgery, with prior CABG since the early 1980s (7,8), but even with
and both mortality and morbidity can be even higher in the addition of stents, PCI of patients with prior CABG has
elderly, unstable patients with additional risk factors (1). been associated with worse outcomes than PCI of patients
Patients with one or more prior CABG operations are an without prior CABG (9,10).
Previous randomized trials of CABG versus PCI ex-
From the *Tucson VA Medical Center and the University of Arizona, Tucson,
Arizona; †Hines VA Cooperative Studies, Hines, Illinois; ‡Denver VA Medical
cluded patients with prior CABG operations and did not
Center and the University of Colorado, Denver, Colorado; and the §New York VA include stents and other innovations that have changed
Medical Center and the New York Univerity, New York, New York. The Cooperative revascularization technique (8 –12). This study reports the
Studies Program of the United States Department of Veterans Affairs Research and
Development Service funded this study. long-term survival of 760 revascularized patients (142 in the
Manuscript received August 8, 2002; accepted August 26, 2002. randomized trial, 512 in the physician-directed registry,
1952 Morrison et al. JACC Vol. 40, No. 11, 2002
PCI Versus Redo-CABG for Myocardial Ischemia December 4, 2002:1951–4
unstable angina or revascularization consistently favor alternative to CABG for some patients with medically
CABG, and the log-rank tests were statistically different. refractory myocardial ischemia and high risk of adverse
Table 3 presents the proportions of patients with various outcome with CABG, to the subset with prior CABG
additional risk factors who were directed by physicians to (13,14). Additionally, the registry data demonstrate that for
PCI (physician-directed registry) or who chose PCI for the specific subset of patients with prior CABG surgeries,
themselves (patient-choice registry). Percutaneous coronary both our physicians and patients chose PCI by a 2:1 margin
intervention was selected by over a 2:1 ratio in both registry and among the patient-choice cohort a survival advantage
subgroups (70% were assigned to PCI and 30% to CABG in with PCI was demonstrated.
both registry subgroups). The PCI assignment frequency Numerous single-center and multicenter registries have
was considerably greater than 50% in all subsets other than documented that CABG carries a higher mortality and
the left ventricular ejection fraction ⬍0.35 in the patient- morbidity when it is applied to patients with one or more
choice subgroup. prior CABG surgeries than when it is applied to patients
with no prior CABG (1– 6). Largely in response to this
DISCUSSION need, PCI has been applied to this high-risk cohort (7–10).
The data reported here extend the conclusion of the Despite the use of stents, the outcome of PCI in patients
AWESOME randomized trial and registry that PCI is an with prior CABG has also been worse than PCI among
patients with no prior CABG (8 –10).
Table 3. The Percentage Allocation to PCI Among Physician- The 1999 update of the American College of Cardiology/
Directed and Patient-Choice Patients With Prior CABG American Heart Association (ACC/AHA) guidelines for
According to Additional Risk Factors at Baseline cardiac surgery emphasizes the high-risk nature of patients
Physician-Directed Patient-Choice with prior CABG (1). The ACC/AHA guidelines empha-
High-Risk Subset (n ⴝ 719) (n ⴝ 119) size the need for trials, which include stents, drugs, and
All prior CABG 70% 70% modern myocardial protection (1). In its review of previous
Prior CABG and trials, the guideline emphasizes the following: inadequate
Age ⬎70 71% 69% sample sizes, which derive in part from inclusion of only
AMI ⬍7 days 71% 67%
LVEF ⬍0.35 78% 40%*
lower risk patients with inadequate event rates; short follow-
Prior PCI 76% 71% up; and combined end-points which include myocardial
Diabetes 74% 81%* infarction (1). This report addresses these issues and con-
Prior stroke 80%* 70% stitutes the only attempt to prospectively randomize patients
Three-vessel disease 61%* 70%
with one or more prior heart surgeries between revascular-
TIMI no flow 69% 65%
ization alternatives.
*Statistically significant difference between overall PCI assignment rate and PCI
assignment rate for the particular risk group, p ⬍ 0.01.
The primary usefulness of the physician-directed registry
AMI ⫽ acute myocardial infarction. Other abbreviations as in Table 1. is in documenting what patient characteristics led our
1954 Morrison et al. JACC Vol. 40, No. 11, 2002
PCI Versus Redo-CABG for Myocardial Ischemia December 4, 2002:1951–4
physicians to favor one option or the other. The patient- 3. Edwards FH, Grover FL, Shroyer AL, Schwartz M, Bero J. The
Society of Thoracic Surgeons National Cardiac Surgery Database:
choice registry, on the other hand, because it includes current risk assessment. Ann Thorac Surg 1997;63:903–8.
patients who were acceptable to both operators, documents 4. Hannan EL, Kilburn HJ, O’Donnell JF, Lukacik G, Shields EP.
the factors that influence patients to favor one option or the Adult open heart surgery in New York State: an analysis of risk factors
and hospital mortality rates. JAMA 1990;264:2768 –74.
other. The findings show that both physicians and patients 5. Jones RH, Hannan EL, Hammermeister KE, et al. Identification of
preferred PCI by a 2:1 margin. Equally provocative, survival preoperative variables needed for risk adjustment of short-term mor-
was uniformly higher with PCI, although statistically sig- tality after coronary artery bypass graft surgery: the Working Group
Panel on the Cooperative CABG Database Project. J Am Coll Cardiol
nificant only for the patient-choice registry. 1996;28:1478 –87.
This subset study demonstrates the primary problem 6. Grover FL, Johnson RR, Marshall G, Hammermeister KE, and the
Department of Veterans Affairs Cardiac Surgeons. Factors predictive
encountered in the AWESOME trial, namely the difficulty of operative mortality among coronary artery bypass subsets. Ann
in convincing physicians or patients to permit random Thorac Surg 1993;56:1296 –307.
allocation of high-risk cohorts. Despite all the efforts 7. Douglas JS Jr, Gruentzig AR, King SB III, et al. Percutaneous
transluminal coronary angioplasty in patients with prior coronary
involved in this nationwide trial, the majority of medically bypass surgery. J Am Coll Cardiol 1983;2:745–54.
refractory patients with prior CABG were allocated either 8. Piana RN, Moscucci M, Cohen DJ, et al. Palmaz-Schatz stenting for
by physician direction or patient choice. treatment of focal vein graft stenosis: immediate results and long-term
outcome. J Am Coll Cardiol 1994;23:1296 –304.
In conclusion, PCI may be the preferred revascularization 9. Savage MP, Douglas JS, Fischman DL, et al. Stent placement
strategy for many patients with one or more prior CABG compared with balloon angioplasty for obstructed coronary bypass
grafts. N Engl J Med 1997;337:740 –7.
surgeries. 10. Verghese M, Berger PB, Lennon RJ, Gersh BJ, Holmes DR, Jr.
Comparison of percutaneous interventions for unstable angina pectoris
Reprint requests and correspondence: Dr. Douglass A. Morri- with and without previous coronary artery bypass grafting. Am J
Cardiol 2000;86:931–7.
son, Director, Cardiac Catheterization Laboratory, Southern
11. Lytle B. Prior CABG: reoperation. In: Morrison DA, Serruys PW,
Arizona Veterans Affairs Healthcare System, Professor of Medi- editors. High Risk Cardiac Revascularization and Clinical Trials.
cine and Radiology, University of Arizona, (111 C) SAVAHCS, London: Martin Dunitz, 2002:257–64.
3601 S. Sixth Ave., Tucson, Arizona 85723. E-mail: 12. Esposito R. The MIDCAB or off-pump and other innovative surgical
options. In: Morrison DA, Serruys PW, editors. High Risk Cardiac
douglass.morrison@med.va.gov.
Revascularization and Clinical Trials. London: Martin Dunitz, 2002:
453–67.
13. Morrison DA, Sethi G, Sacks J, et al., for the investigators of the
Angina With Extremely Serious Operative Mortality Evaluation
REFERENCES (AWESOME). Percutaneous coronary intervention versus coronary
artery bypass graft surgery for patients with medically refractory
1. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA guidelines for myocardial ischemia and risk factors for adverse outcome with bypass.
coronary artery bypass graft surgery: a report of the American College A Multicenter Randomized Trial. J Am Coll Cardiol 2001;38:143–9.
of Cardiology/American Heart Association Task Force on Practice 14. Morrison DA, Sethi G, Sacks J, et al., for the AWESOME Investi-
Guidelines (Committee to Revise the 1991 Guidelines for Coronary gators. Percutaneous coronary interventions versus coronary bypass
Artery Bypass Graft Surgery). J Am Coll Cardiol 1999;34:1262–346. graft surgery for patients with medically refractory myocardial ischemia
2. Lytle BW, Loop FD, Taylor PC, et al. Vein graft disease: the clinical and risk factors for adverse outcomes with bypass. The VA
impact of stenoses in saphenous vein bypass grafts to coronary arteries. AWESOME multicenter registry: comparison with the randomized
J Thorac Cardiovasc Surg 1992;103:831–40. clinical trial. J Am Coll Cardiol 2002;39:266 –73.